Owing to the strong correlation between PAI-1 levels and prognosis in patients with breast cancer, PAI-1 has been recommended as a biomarker for therapeutic decisions in patients with clinically node-negative breast cancer [54]. The gene discussed is SERPINE1; the disease is breast carcinoma.